Name | Number of supported studies | Average coverage | |
---|---|---|---|
adipocyte | 8 studies | 46% ± 12% | |
endothelial cell | 4 studies | 19% ± 3% | |
endothelial cell of lymphatic vessel | 3 studies | 23% ± 7% |
Insufficient scRNA-seq data for expression of GABRE at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 98% | 3745.18 | 167 / 170 | 77% | 26.39 | 354 / 459 |
pancreas | 93% | 1672.92 | 305 / 328 | 80% | 14.36 | 143 / 178 |
lung | 99% | 3022.67 | 571 / 578 | 69% | 17.41 | 794 / 1155 |
bladder | 95% | 4219.14 | 20 / 21 | 72% | 17.06 | 364 / 504 |
intestine | 79% | 1935.94 | 763 / 966 | 72% | 9.73 | 381 / 527 |
thymus | 99% | 3963.95 | 649 / 653 | 51% | 4.61 | 309 / 605 |
ovary | 77% | 1688.51 | 139 / 180 | 72% | 12.05 | 308 / 430 |
esophagus | 84% | 3530.99 | 1210 / 1445 | 63% | 21.77 | 116 / 183 |
prostate | 100% | 9554.98 | 244 / 245 | 44% | 3.93 | 220 / 502 |
kidney | 81% | 1660.22 | 72 / 89 | 46% | 5.97 | 416 / 901 |
breast | 100% | 8946.16 | 459 / 459 | 26% | 3.00 | 291 / 1118 |
skin | 99% | 4235.53 | 1785 / 1809 | 3% | 0.22 | 14 / 472 |
adipose | 100% | 10868.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.10 | 1 / 1 |
spleen | 97% | 2326.75 | 234 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 96% | 2692.96 | 1283 / 1335 | 0% | 0 | 0 / 0 |
stomach | 40% | 717.48 | 145 / 359 | 55% | 8.82 | 157 / 286 |
heart | 90% | 2067.97 | 775 / 861 | 0% | 0 | 0 / 0 |
liver | 31% | 436.85 | 71 / 226 | 55% | 6.39 | 224 / 406 |
tonsil | 0% | 0 | 0 / 0 | 84% | 15.94 | 38 / 45 |
adrenal gland | 61% | 806.21 | 157 / 258 | 17% | 2.20 | 38 / 230 |
brain | 9% | 290.05 | 244 / 2642 | 8% | 0.88 | 56 / 705 |
muscle | 7% | 77.36 | 54 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2001226 | Biological process | negative regulation of chloride transport |
GO_1904862 | Biological process | inhibitory synapse assembly |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_0060078 | Biological process | regulation of postsynaptic membrane potential |
GO_0051932 | Biological process | synaptic transmission, GABAergic |
GO_0007214 | Biological process | gamma-aminobutyric acid signaling pathway |
GO_0005886 | Cellular component | plasma membrane |
GO_1902495 | Cellular component | transmembrane transporter complex |
GO_0098794 | Cellular component | postsynapse |
GO_0043005 | Cellular component | neuron projection |
GO_0034707 | Cellular component | chloride channel complex |
GO_0045202 | Cellular component | synapse |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_1902711 | Cellular component | GABA-A receptor complex |
GO_0032590 | Cellular component | dendrite membrane |
GO_0004890 | Molecular function | GABA-A receptor activity |
GO_0005254 | Molecular function | chloride channel activity |
GO_0022851 | Molecular function | GABA-gated chloride ion channel activity |
GO_0008503 | Molecular function | benzodiazepine receptor activity |
Gene name | GABRE |
Protein name | Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon) Gamma-aminobutyric acid type A receptor subunit epsilon |
Synonyms | |
Description | FUNCTION: GABA, the major inhibitory neurotransmitter in the vertebrate brain, mediates neuronal inhibition by binding to the GABA/benzodiazepine receptor and opening an integral chloride channel. |
Accessions | F2Z2H5 P78334 ENST00000370328.4 [P78334-1] ENST00000417300.1 ENST00000441219.5 |